April 26th 2024
New data reinforced the safety and tolerability profile of this antiretroviral therapy for this patient population who are virologically suppressed.
HIV Prevention Plan in Namibia Shows High Prevalence of Risk Factors
December 2nd 2021Study authors from the CDC found that girls in the sub-Saharan country of Namibia are at increased risk for HIV acquisition and also experience risk factors that make them eligible for HIV infection prevention programs.
Read More
Provider Stigma Can Prevent Injection Drug Users from Receiving HIV PrEP
November 13th 2021Bias against injection drug users can inhibit them from receiving potentially lifesaving care, such as HIV pre-exposure prophylaxis (PrEP). Community-based responses like syringe service programs help combat this stigma.
Watch
Lack of Improvement in HIV Infections and Use Prevention Services Among PWID
November 8th 2021People who inject drugs (PWID) remain at risk of HIV infection, according to a recent report by the CDC, which found HIV infection and HIV-associated behaviors remained steady between 2015 and 2018.
Read More
Contemporary Issues on the Treatment of Women Living with HIV in the US
October 19th 2021The increasing presence of multiple non-AIDS comorbidities in women and others living with HIV challenges clinicians to steer away from the approach of optimizing individual chronic conditions but to think more holistically.
Read More